Carregant...
Ibrutinib-induced acute kidney injury via interstitial nephritis
The introduction of Bruton's tyrosine kinase inhibitor ibrutinib has made a significant progress in the treatment of chronic lymphocytic leukemia and other B-cell malignancies. Due to the reduction of cytokine release, it is effective in chronic graft-versus-host disease, and its use has also b...
Guardat en:
| Publicat a: | Ren Fail |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889134/ https://ncbi.nlm.nih.gov/pubmed/33567947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/0886022X.2021.1874985 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|